AI-Driven Precision Medicine Market Likely to reach ~USD 10 billion by 2035.
An extensive study of propelling opportunities in, “AI-Driven Precision Medicine Market Size, Share, Growth Opportunity Analysis Report by Technology Type (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Computer Vision, Reinforcement Learning, Big Data Analytics, Others), Component, Data Type, Delivery Mode, Therapeutic Area, Application, End-user and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A comprehensive report of growing market landscapes in the AI-driven precision medicine sector uncovering key growth drivers including niche market leadership, technology-enabled distribution, and increasing consumer needs supporting AI-driven precision medicine potential to scale globally.
AI-Driven Precision Medicine Market Forecast 2035:
According to the report, the AI-driven precision medicine market is anticipated to grow from USD 0.7 Billion in 2025 to USD 9.7 Billion in 2035 at an impressive CAGR of 26.8% during the forecast. Growing demand for personalized therapies, faster diagnoses, and a global shift toward value in healthcare are some of the key drivers of the AI-led precision medicine market. Specifically, in cancer, genetic diseases, and chronic diseases, AI provides physicians with the ability to assess disease risk, select the appropriate therapeutic intervention, and track and monitor their patient's outcomes. AI offers data-driven healthcare; with better outcomes and fewer side effects, it allows patients and providers to move away from trial and error therapies. New AI products were introduced in Europe and North America in 2024 and 2025 that combine genomic testing, digital imaging, and clinical records to provide information in real time. For example, Tempus launched SmartPath, enabling physicians to change a cancer patient's treatment plan remotely and in real-time.
Similarly, new products such as PathAI and Paige enhance cancer accuracy of diagnosis through biopsy images, producing less inaccurate results, and saving time. These emerging innovations are providing opportunities for AI development across the spectrum of healthcare, from large hospitals, to small clinics, to home care. However, the market continues to face challenges. Slow uptake is due in part to expensive technology, stringent data privacy laws, and poor access to digital health infrastructure, particularly in low-resource settings.
Moreover, many countries also do not have specific policies to regulate how artificial intelligence tools are able to operate in healthcare and to what extent. As companies and governments continue to invest in safe, understandable, and scalable artificial intelligence, the possibilities for expansion are substantial. Increased connectivity, real world data, and mobile technologies are driving artificial intelligence in precision medicine wellness initiatives and making them more universally available for people from children to older patients and across several diseases.
“Key Driver, Restraint, and Growth Opportunity Defining the Neurostimulation Devices Market
AI-enabled precision medicine is becoming increasingly commonplace, particularly as research expands in cancer, rare diseases, and genetic disorders. As many patients are ill-suited to one-size-fits-all treatments, physicians have begun utilizing AI tools to assess disposition patients for the best possible care, by comparing genetic, lifestyle, health, and demographic information. Companies like Tempus and PathAI are leading the charge by developing machine-learning that can match patients to the correct treatment, and reduce the time and distance to this care process.
Despite the promising developments in the field of AI supported precision medicine, the equitable access to tools and technology remain questionable. It is even less equitable in low-income communities, urban underserved or rural communities, or hospitals where the available funds and infrastructure allows for either limited digital integrated funding or resources do not permit AI. Some health care providers would not have the training needed to use these AI systems regardless of the digital endowment; additionally, issues persist in a) interpretation of patient privacy, b) intellectual property to protect AI or c) acceptable reimbursement schematic. These areas of unclear policy create a lag in administrative and resource development leading to a digital divide between traditionally high resource/high-tech care patterns in certain regions and the care in under-resourced regions.
While many invasiveness to healthcare and precision medicine are still to be determined, the outlook is better than ever. AI permits for much more personalized care and proactive care. Real-time clinical decision platforms, AI-enabled diagnostic tools, and wearable sensors that can collect data and feed that data back into treatment models are all helping clinicians to make better and faster decisions. With these tools becoming more user-friendly, lower cost, and embedded into every healthcare system, they seek to give patients easier and more profitable precision medicine while also affording patients things like early diagnosis, targeted treatment, and better outcomes in the future.
Expansion of AI-Driven Precision Medicine Market
"Universal Access, Aging Population, and Innovation Fuel the Diverse Growth of the AI-Driven Precision Medicine Market"
- The AI-driven precision medicine market is growing rapidly in response to a demonstrated commitment to awareness of, and alternatives to central, traditional diagnostic and treatment processes. Given the marked increases in cancer, chronic, and aging conditions, more and more doctors and patients are exploring AI tools to co-create and execute treatments when traditional therapies become ineffective, and patients are utilizing AI patient support tools preferred by their doctors. Patients like AI-supported care as it can help with unnecessary medications, expedite diagnosis, and provide more accurate predictions through the genetic and clinical data they provide.
- In response to this demand, companies are developing AI platforms incorporating wearable health devices, at-home testing kits, and mobile tools. These tools provide patient data in real time, predicting risk, improving the experience, and changing treatment plans without requiring a hospital visit. These innovations support new models of AI; for instance, AI models that help develop models of the care plan while using the patient's real-time feedback on their therapy. These innovations improve the safety of care, progressing toward the desired outcome, or potentially replacing care plans, ultimately saving money through reduced requested care by the patient.
- As chronic disease and aging populations continue to rise globally, AI-powered precision medicine could prove to be a scalable, tech-based solution to improve access to long-term care, while minimizing over utilizing drugs and unnecessary treatment. It emphasizes patients in care by integrating smart technology, affordability, and convenience.
Regional Analysis of AI-Driven Precision Medicine Market
- Due to the strong healthcare infrastructure, advanced genomic research and broad insurance coverage for patients, it is becoming common for AI tools to help lead personalized treatment plans in the U.S., particularly in oncology, rare disease and genetic disorders. Tempus and PathAI, as examples, have recently partnered with hospitals to provide real-time, AI-inspired treatment plan suggestions through mobile apps and cloud platforms. Tempus had extended SmartPath into some of the largest oncology networks in 2024. PathAI developed digital pathology tools that allow for the accelerated diagnosis of cancer and aims to expand access to AI-enabled treatment through mobile cloud-based apps.
- Worldwide, there is a momentum for precision medicine with AI, as countries continue to invest in digital health programs. For example, in Europe, national health systems in Germany and U.K. are integrating AI for early cancer screening and rare disease identification. In India, rural clinics are utilizing AI-based diagnostic tools which are being supported by mobile clouds and apps. In China, AI-based research centers are considering higher scaling aimed at drug discovery and genomics. In Southeast Asia and Africa with lower income countries, mobile-based AI service use to provide low-cost diagnostics is an effective way to close the access gap. With more governments supporting AI healthcare initiatives, and cloud and mobile tools making data easier to share, AI-driven precision medicine is expanding worldwide bringing faster, more accurate and personalized care to more people, regardless of location.
Prominent players operating in the AI-driven driven precision medicine market include Berg Health, Butterfly Network, Caption Health, Flatiron Health (Roche), Foundation Medicine (Roche), Freenome, Genalyte, Google Health / DeepMind, Guardant Health, IBM Watson Health, Microsoft Healthcare (AI for Health), NVIDIA Corporation, Oracle Health Sciences, Owkin, Paige AI, PathAI, Philips Healthcare, Siemens Healthineers, Tempus Labs, Zebra Medical Vision, Other key Players.
The AI-driven precision medicine has been segmented as follows:
AI-Driven Precision Medicine Market Analysis, by Technology Type
- Machine Learning (ML)
- Deep Learning (DL)
- Natural Language Processing (NLP)
- Computer Vision
- Reinforcement Learning
- Big Data Analytics
- Others
AI-Driven Precision Medicine Market Analysis, by Component
- Software
- Predictive Modeling
- Decision Support
- Others
- Services
- Implementation
- Consulting
- Data Management
- Others
- Hardware
- AI chips
- Edge Devices
- Cloud Infrastructure
- Others
AI-Driven Precision Medicine Market Analysis, by Data Type
- Genomic Data
- Clinical Data (EHRs, medical imaging)
- Behavioral Data
- Environmental & Lifestyle Data
- Proteomic & Metabolomic Data
- Others
AI-Driven Precision Medicine Market Analysis, by Delivery Mode
- Cloud-based AI Solutions
- On-premise AI Systems
AI-Driven Precision Medicine Market Analysis, by Therapeutic Area
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Others (Autoimmune, Endocrine Disorders)
AI-Driven Precision Medicine Market Analysis, by Application
- Oncology (Cancer Genomics, Tumor Profiling)
- Cardiology
- Neurology
- Immunology
- Pharmacogenomics
- Rare Diseases
- Infectious Diseases (e.g., COVID-19 AI applications)
- Others (Metabolic, Respiratory, etc.
AI-Driven Precision Medicine Market Analysis, by End-User
- Hospitals & Clinics
- Research & Academic Institutions
- Pharmaceutical & Biotechnology Companies
- Clinical Laboratories
- Government & Public Health Agencies
- Others
AI-Driven Precision Medicine Market Analysis, by Region
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- South America
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact US
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
+91-8788594158
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. AI-Driven Precision Medicine Market Outlook
- 2.1.1. AI-Driven Precision Medicine Market Size (Value - US$ Billion), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. AI-Driven Precision Medicine Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Healthcare & Pharmaceutical Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Source Roadmap and Developments
- 3.4. Trade Analysis
- 3.4.1. Import & Export Analysis, 2025
- 3.4.2. Top Importing Countries
- 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
- 3.5.1. Manufacturer
- 3.5.2. Supply Chain
- 3.5.3. End Consumer
- 3.6. Raw Material Analysis
- 3.1. Healthcare & Pharmaceutical Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising Incidence of Genetic Disorders with increasing Technological Advancements
- 4.1.2. Restraints
- 4.1.2.1. Expensive AI Models, Strict Regulatory Frameworks limiting the AI-Driven Precision Medicine Industry
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.4.1. Component Suppliers
- 4.4.2. AI-Driven Precision Medicine Manufacturers
- 4.4.3. Dealers/Distributors
- 4.4.4. Wholesalers/ E-commerce Platform
- 4.4.5. End-users/ Customers
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
- 4.6.1. Regional Pricing Analysis
- 4.6.2. Segmental Pricing Trends
- 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. AI-Driven Precision Medicine Market Demand
- 4.9.1. Historical Market Size – in Value (US$ Billion), 2021-2024
- 4.9.2. Current and Future Market Size – in Value (US$ Billion), 2025–2035
- 4.9.2.1. Y-o-Y Growth Trends
- 4.9.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. AI-Driven Precision Medicine Market Analysis, by Technology Type
- 6.1. Key Segment Analysis
- 6.2. AI-Driven Precision Medicine Market Size (Value - US$ Billion), Analysis, and Forecasts, by Technology Type, 2021-2035
- 6.2.1. Machine Learning (ML)
- 6.2.2. Deep Learning (DL)
- 6.2.3. Natural Language Processing (NLP)
- 6.2.4. Computer Vision
- 6.2.5. Reinforcement Learning
- 6.2.6. Big Data Analytics
- 6.2.7. Others
- 7. AI-Driven Precision Medicine Market Analysis, by Component
- 7.1. Key Segment Analysis
- 7.2. AI-Driven Precision Medicine Market Size (Value - US$ Billion), Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Software
- 7.2.1.1. Predictive Modeling
- 7.2.1.2. Decision Support
- 7.2.1.3. Others
- 7.2.2. Services
- 7.2.2.1. Implementation
- 7.2.2.2. Consulting
- 7.2.2.3. Data Management
- 7.2.2.4. Others
- 7.2.3. Hardware
- 7.2.3.1. AI chips
- 7.2.3.2. Edge Devices
- 7.2.3.3. Cloud Infrastructure
- 7.2.3.4. Others
- 7.2.1. Software
- 8. AI-Driven Precision Medicine Market Analysis, by Data Type
- 8.1. Key Segment Analysis
- 8.2. AI-Driven Precision Medicine Market Size (Value - US$ Billion), Analysis, and Forecasts, by Technology, 2021-2035
- 8.2.1. Genomic Data
- 8.2.2. Clinical Data (EHRs, medical imaging)
- 8.2.3. Behavioral Data
- 8.2.4. Environmental & Lifestyle Data
- 8.2.5. Proteomic & Metabolomic Data
- 8.2.6. Others
- 9. AI-Driven Precision Medicine Market Analysis, by Delivery Mode
- 9.1. Key Segment Analysis
- 9.2. Omega-3 Market Size (Value - US$ Billion), Analysis, and Forecasts, by Distribution Channel, 2021-2035
- 9.2.1. Cloud-based AI Solutions
- 9.2.2. On-premise AI Systems
- 10. AI-Driven Precision Medicine Market Analysis, by Therapeutic Area
- 10.1. Key Segment Analysis
- 10.2. AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, by End-User, 2021-2035
- 10.2.1. Cancer
- 10.2.2. Cardiovascular Diseases
- 10.2.3. Neurological Disorders
- 10.2.4. Infectious Diseases
- 10.2.5. Others (Autoimmune, Endocrine Disorders)
- 11. AI-Driven Precision Medicine Market Analysis, by Application
- 11.1. Key Segment Analysis
- 11.2. AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, by End-User, 2021-2035
- 11.2.1. Oncology (Cancer Genomics, Tumor Profiling)
- 11.2.2. Cardiology
- 11.2.3. Neurology
- 11.2.4. Immunology
- 11.2.5. Pharmacogenomics
- 11.2.6. Rare Diseases
- 11.2.7. Infectious Diseases (e.g., COVID-19 AI applications)
- 11.2.8. Others (Metabolic, Respiratory, etc.)
- 12. AI-Driven Precision Medicine Market Analysis, by End-user
- 12.1. Key Segment Analysis
- 12.2. AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, by End-User, 2021-2035
- 12.2.1. Hospitals & Clinics
- 12.2.2. Research & Academic Institutions
- 12.2.3. Pharmaceutical & Biotechnology Companies
- 12.2.4. Clinical Laboratories
- 12.2.5. Government & Public Health Agencies
- 12.2.6. Others
- 13. AI-Driven Precision Medicine Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- North America AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- North America AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- USA
- Canada
- Mexico
- USA AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Canada AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Mexico AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Europe AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- Europe AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Nordic Countries
- Poland
- Russia & CIS
- Rest of Europe
- Germany AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- United Kingdom AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- France AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Italy AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- Distribution Channel
- End-user
- Spain AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Netherlands AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Nordic Countries AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Poland AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Russia & CIS AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Rest of Europe AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Asia Pacific AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- East Asia AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- China
- India
- Japan
- South Korea
- Australia and New Zealand
- Indonesia
- Malaysia
- Thailand
- Vietnam
- Rest of Asia-Pacific
- China AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- India AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Japan AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- South Korea AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Australia and New Zealand AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Indonesia AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Malaysia AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Thailand AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Vietnam AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Rest of Asia Pacific AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- Distribution Channel
- End-user
- Middle East AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- Middle East AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- Turkey
- UAE
- Saudi Arabia
- Israel
- Rest of Middle East
- Turkey AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- UAE AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Saudi Arabia AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Israel AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Rest of Middle East AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Africa AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- Africa AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- South Africa
- Egypt
- Nigeria
- Algeria
- Rest of Africa
- South Africa AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Egypt AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Nigeria AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Algeria AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Rest of Africa AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- South America AI-Driven Precision Medicine Market Analysis
- Key Segment Analysis
- Regional Snapshot
- Central and South Africa AI-Driven Precision Medicine Market Size (Volume-Million Units and Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- Device Type
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Country
- Brazil
- Argentina
- Rest of South America
- Brazil AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Argentina AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Rest of South America AI-Driven Precision Medicine Market
- Country Segmental Analysis
- Technology Type
- Component
- Data Type
- Delivery Mode
- Therapeutic Area
- Application
- End-user
- Key Players/ Company Profile
- Berg Health
- Company Details/ Overview
- Company Financials
- Key Customers and Competitors
- Business/ Industry Portfolio
- Product Portfolio/ Specification Details
- Pricing Data
- Strategic Overview
- Recent Developments
- Butterfly Network
- Caption Health
- Flatiron Health (Roche)
- Foundation Medicine (Roche)
- Freenome
- Genalyte
- Google Health / DeepMind
- Guardant Health
- IBM Watson Health
- Microsoft Healthcare (AI for Health)
- NVIDIA Corporation
- Oracle Health Sciences
- Owkin
- Paige AI
- PathAI
- Philips Healthcare
- Siemens Healthineers
- Tempus Labs
- Zebra Medical Vision
- Other key Players
- Berg Health
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase and Others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players product portfolio
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources includes primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
